Stock Price Quote

LAURUS LABS LTD.

NSE : LAURUSLABSBSE : 540222ISIN CODE : INE947Q01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE412.0020.05 (+5.12 %)
PREV CLOSE ( ) 391.95
OPEN PRICE ( ) 406.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9591
TODAY'S LOW / HIGH ( )402.65 420.30
52 WK LOW / HIGH ( )298 460
NSE411.6519.75 (+5.04 %)
PREV CLOSE( ) 391.90
OPEN PRICE ( ) 410.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 272660
TODAY'S LOW / HIGH( ) 402.15 421.00
52 WK LOW / HIGH ( )295 459.95
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-09 2005
Management Info
Malempati Venugopala Rao - Chairman - Managing Director
Registered Office

Address Plot No.21, J N Pharma City,Parawada, ,
Vishakhapatnam,
Andhra Pradesh-531021

Phone 0891 3061222

Email nagaraj.a@lauruslabs.com

Website www.lauruslabs.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

06Apr Laurus Labs informs about compliance c
Laurus Labs has informed that in terms of Regulation 7(3) of the Listing..
27Mar Laurus Labs donates Hydroxychloroquine
Laurus Labs has donated 1 lakh tablets of Hydroxychloroquine (HCQ) Table..
13Mar Laurus Labs informs about interim divi
Laurus Labs has informed that the Board of Directors of the Company in t..
04Mar Board Meeting Intimation for Consider
Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directo..
02Mar Announcement under Regulation 30 (LOD
Mr. Ramesh Subrahmanian has expressed his intention to resign as an Inde..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit779.52949.94
Gross Profit 859.26 1212.19
Operating Profit 1530.23675.83
Net Sales 7209.9222361.48

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  17880.50 (2.42%)
M.Cap ( in Cr)37994.81
Pfizer (BSE)
peergroup  4406.50 (3.76%)
M.Cap ( in Cr)20158.74
Divis Lab (BSE)
peergroup  2313.90 (6.80%)
M.Cap ( in Cr)61426.77
Glaxosmithkline Phar (BSE)
peergroup  1393.25 (11.41%)
M.Cap ( in Cr)23602.50
Astrazeneca Pharma I (BSE)
peergroup  2672.65 (4.17%)
M.Cap ( in Cr)6681.63

Shareholding Pattern

MUTUAL FUNDS/UTI 4.92%
PROMOTERS 32.58%
NON-INSTITUTION 24.8%
FI/BANKS/INSURANCE 0.08%
GOVERNMENT 0%
FII 0%

About Laurus Labs Ltd.

Laurus Labs Ltd. was incorporated in the year 2005. Its today's share price is 412. Its current market capitalisation stands at Rs 4404.88 Cr. In the latest quarter, company has reported Gross Sales of Rs. 22919.16 Cr and Total Income of Rs.23080.68 Cr. The company's management includes Ravindranath Kancherla, Rajesh Koshy Chandy, Aruna Bhinge, Narendra Ostawal, Venkata Lakshmana Rao Chunduru, Chandrakanth Chereddi, Venkata Ravi Kumar Vantaram, Chava Satyanarayana, Malempati Venugopala Rao.

It is listed on the BSE with a BSE Code of 540222 , NSE with an NSE Symbol of LAURUSLABS and ISIN of INE947Q01010. It's Registered office is at Plot No.21, J N Pharma City,Parawada, Vishakhapatnam-531021, Andhra Pradesh. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, SR Batliboi & Associates LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X